tibolone has been researched along with cyclin d1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bozdoğan, O; Noyan, V; Sağsöz, N; Yücel, A | 1 |
Brinkhuis, M; Franke, HR; Jansen, GH; Vermes, I; Wolbers, F | 1 |
1 trial(s) available for tibolone and cyclin d1
Article | Year |
---|---|
The effects of hormone therapy, estrogen therapy and tibolone on apoptosis and cyclin D1 expression in postmenopausal vaginal epithelium.
Topics: Adult; Apoptosis; Biomarkers; Biopsy, Needle; Cyclin D1; Epithelium; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Probability; Prognosis; Reference Values; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Treatment Outcome; Vagina | 2005 |
1 other study(ies) available for tibolone and cyclin d1
Article | Year |
---|---|
Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dydrogesterone; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Hormone Replacement Therapy; Humans; In Vitro Techniques; Norpregnenes; Progestins; Receptors, Estrogen; RNA, Messenger | 2008 |